Here are the Differences in splicing factors may predict type 2 diabetes remission in the CORDIOPREV study journals presenting the latest research across various disciplines. From social sciences to technology, each article is expected to provide valuable insights to our readers.
Lexus sedans differences in models, cultural differences in business, gender differences in communication, individual differences in learning, differences in splicing factors of production, differences in splicing factors of 36, differences in splicing factors of 48.
Differences in splicing factors may predict type 2 diabetes remission in the CORDIOPREV study
Alternative splicing is a post-transcriptional process resulting in multiple protein isoforms from a single gene. Abnormal splicing may lead to metabolic diseases, including type 2 diabetes mellitus (T2DM). To identify the splicing factor expression that predicts T2DM remission in coronary heart disease (CHD) patients, we identified newly diagnosed T2DM at baseline (n = 190) from the CORDIOPREV study. Patients were classified as Responders (T2DM remission during 5 years without antidiabetic drugs) or non-Responders. Baseline dysregulation in 5 splicing factors (MBNL1, RBM5, hnRNP G/RBMX, CD44, NT5E) distinguished Responders from non-Responders. Adding these factors to clinical variables [AUC = 0.67], insulin resistance, and beta-cell indexes [AUC = 0.76], improved T2DM remission prediction [AUC = 0.80]. Cox regression analysis showed those with higher remission scores had a 2.63-fold increased remission probability. To conclude, a set of splicing factors that contribute to pr edicting T2DM remission in patients with CHD has been identified. Further research is needed to elucidate these findings' clinical relevance. © 2024 The Authors
Authors : Ojeda-Rodriguez A.; Torres-Peña J.D.; Arenas-de Larriva A.P.; Rangel-Zuñiga O.A.; Podadera-Herreros A.; Boughanem H.; G-García M.E.; López-Moreno A.; Katsiki N.; Luque R.M.; Perez-Martinez P.; Delgado-Lista J.; Yubero-Serrano E.M.; Lopez-Miranda J.
Source : Elsevier Inc.
Article Information
| Year | 2025 |
| Type | Article |
| DOI | 10.1016/j.isci.2024.111527 |
| ISSN | 25890042 |
| Volume | 28 |
You can download the article here
If You have any problem, contact us here